Nicholas Gordon

Co-chair, Brainstorm Design; Editor, Asia at Fortune

Nicholas Gordon is a Hong Kong-based associate editor, where he assists with audience development and commentary coverage for the Asia-Pacific region. Before joining Fortune, he worked as a content manager for a Hong Kong-based think tank working on regional economic development issues. He has a masters in international relations from Oxford University and a bachelors in social studies from Harvard College.

Chuyuan Li

Chairman of Guangzhou Pharmaceutical Holdings Limited

Mr. Li Chuyuan was bachelor degree in chemistry from Sun Yat-sen University and master of EMBA in Lingnan college from Sun Yat-sen University. He is Senior Economist, Senior Engineer (professor level), the expert enjoying special government allowances of the State Council, China National Model Workers and Representative of Guangzhou Municipal Communist Party of China Party. He had been awarded with the 2nd Prize of the National Prize for Progress in Science and Technology, Guangdong " Ding Ying science and Technology Award ", National Outstanding Entrepreneur, China Top 10 Economic Person of the year 2017, Guangdong Top 10 Innovative Figures, Guangzhou Industrial Leading Talents and the 8th Guangzhou Top 10 Outstanding Young Persons. Being pioneering, pragmatic and innovative, Mr. Li Chuyuan has led Guangzhou Pharmaceutical Holdings Limited (GPHL) to complete the layout of the whole industrial chain, go public as a whole and explore the overseas market. Under his leadership, GPHL has developed from a local pharmaceutical enterprise in south of the Five Ridges to the largest pharmaceutical enterprise as well as the largest production base of Chinese patent medicine in China, with its main business covering Chinese herbal medicine, Chinese patent medicine, chemical medicine, biological medicine, big health products and medical services. In 2021, GPHL became the first enterprise listed in Fortune Global 500 with traditional Chinese medicine as the main business in the world. It ranks No.18 in the Global Most Valuable Pharmaceutical Brands List and takes the 1st place in the Top 100 Chinese Traditional Medicine Pharmaceutical Enterprises List for 11 consecutive years. GPHL strives to grow into the world-class biomedical and health enterprise with special industrial characteristics and unique culture.

Angela Liu

Chairlady of New Hope Liuhe Co., Ltd.& Director of New Hope Group

Angela Liu, Chairlady of New Hope Liuhe Co., Ltd.& New Hope Investment Group, Board Member of New Hope Group Co., Ltd., Board Member of New Hope Dairy.2020 Harvard Business Review China Top 100 CEO, 2019 China Ernst & Young Entrepreneur Award, and China Economic Figure of 2017 by Netease.Angela Liu and her management team are committed to promoting the transformation and upgrading of the New Hope Liuhe Industrial Chain and commit to providing consumers with safe, healthy, good taste and high quality meat products.New Hope Liuhe ranks the 108th among the top 500 Chinese enterprises by Fortune Magazine in 2022.

David Xie

CEO of Lark

David built Lark from scratch and is currently the CEO of Lark.Lark is committed to empowering organizations and team members to be more creative and efficient by providing an all - in - one collaboration platform with messaging, video conferencing, calendar, collaborative documents, cloud storage, email, and Human Capital Management solutions.At present, Lark has been adopted by a large number of enterprises.David received his Master's and Bachelor's degree in Computer Science from Peking University.He joined ByteDance in late 2014. Before that, David had taken a number of roles within Microsoft, Baidu and Kuxun Travel Website.